Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD

Clinical trial NCT00191035 · COMPLETED

Trial details

NCT number: NCT00191035
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2004-03-01
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.